ursodeoxycholic acid has been researched along with Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted in 42 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 29 (69.05) | 18.2507 |
| 2000's | 11 (26.19) | 29.6817 |
| 2010's | 1 (2.38) | 24.3611 |
| 2020's | 1 (2.38) | 2.80 |
| Authors | Studies |
|---|---|
| Okamura, J; Tamai, H | 1 |
| Matanina, NV; Reĭzis, AR | 1 |
| Amano, Y; Hanaoka, T; Ishine, J; Kinoshita, Y; Miyake, T; Oshima, N; Sato, S; Tobita, H | 1 |
| Barril, G; Bartolomé, J; Carreño, V; Castillo, I; Quiroga, JA | 1 |
| Chatzopoulos, D; Kountouras, J; Zavos, C | 1 |
| Dutkiewicz, E; Kryczka, W; Walewska-Zielecka, B | 1 |
| Kumada, H; Tsubota, A | 1 |
| Blum, HE | 1 |
| Fujiyama, S; Hirokawa, S; Masaki, T; Miyakawa, K; Ohkawa, S; Tamai, S; Tanaka, K; Tarao, K | 1 |
| Casanova, RL; Gitlin, N | 1 |
| Hirota, K; Ito, Y; Ohto, M; Omata, M; Takano, S; Uchiumi, K; Yokosuka, O | 1 |
| Hanada, H; Hino, K; Okita, K | 1 |
| Imazeki, F; Omata, M; Yokosuka, O | 1 |
| Salmerón Escobar, FJ | 1 |
| Annovazzi, G; Filippi, T; Magrini, A; Pannullo, A; Puoti, C | 3 |
| Andre, P; Boucher, E; Brissot, P; Deugnier, Y; Guyader, D; Jacquelinet, C; Jouanolle, H; Moirand, R; Ruffault, A; Turlin, B | 1 |
| Angelico, M; Baroni, CD; Bini, A; Capocaccia, L; Del Vecchio, C; Gandin, C; Pescarmona, E; Rapicetta, M; Spada, E | 1 |
| Akiyama, K; Makino, I; Nakamura, K | 1 |
| Giostra, E; Malè, PJ | 1 |
| Chishima, J; Makita, F; Nagamine, T; Nishijima, K; Ojima, T; Saitoh, S; Satoh, K; Takagi, H; Yamada, S; Yamada, T | 1 |
| Goeser, T; Mohler, M; Seipp, S; Stremmel, W; Theilmann, L; Tox, U | 1 |
| Andoh, Y; Beck, Y; Gotoh, M; Kita, Y; Monden, M; Nagao, T; Sakon, M; Teraoka, S; Yokota, K | 1 |
| Moriwaki, H; Muto, Y; Nishigaki, Y; Ohnishi, H | 1 |
| Shiraki, K; Tameda, Y | 1 |
| Imai, Y; Inui, Y; Ito, N; Kawata, S; Kiso, S; Matsuzawa, Y; Tamura, S | 1 |
| Arata, S; Ikeda, M; Kitamura, T; Kondo, M; Morimoto, M; Saito, S; Sakaguchi, T; Sekihara, H; Tanaka, K | 1 |
| Himeno, S; Igura, T; Imai, Y; Inui, Y; Kawata, S; Kiso, S; Maeda, Y; Matsuzawa, Y; Nagase, T; Seki, K; Tamura, S; Tsushima, H; Yamasaki, E | 1 |
| Bruguera, M | 1 |
| Akbaylar, H; Akdogan, M; Batur, Y; Cetinkaya, H; Dokmeci, A; Erden, E; Ersoz, G; Mert, A; Ozbay, G; Ozenirler, S; Senturk, H; Simsek, I; Sonsuz, A; Tabak, F; Tozum, N; Uzunalimoglu, O | 1 |
| Balò, S; Clerici, C; Distrutti, E; Gentili, G; Giansanti, M; Miglietti, M; Morelli, A; Morselli-Labate, AM; Rusticali, AG; Solinas, A | 1 |
| Librant-Suska, M; Warunek, W; Zejc-Bajsarowicz, M | 1 |
| Harada, H; Kamitsukasa, H; Kojima, H; Murai, S; Tokita, H; Yagura, M | 1 |
| Ishikawa, H; Kakisaka, Y; Kashima, K; Mitsuyoshi, H; Nakajima, Y; Nakamura, H; Nakashima, T; Sumida, Y; Yodoi, J; Yoh, T | 1 |
| Tarao, K | 1 |
| Angulo, P; Dickson, ER; Haber, J; Jorgensen, R; Katz, G; Lindor, K; Malkiewicz, I; Neuman, M; Shear, N | 1 |
| Yamanaka, M | 1 |
| Lirussi, F; Okolicsanyi, L | 1 |
| Jávor, T; Pár, A; Patty, I; Vincze, A | 1 |
| Buzzelli, G; Calviani, L; Dattolo, P; Focardi, G; Gentilini, P; Giusti, A; Moscarella, S; Relli, P | 1 |
11 review(s) available for ursodeoxycholic acid and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
| Article | Year |
|---|---|
Apoptosis in hepatitis C.
Topics: Antiviral Agents; Apoptosis; Caspases; Fas Ligand Protein; fas Receptor; Hepacivirus; Hepatitis C; Hepatocytes; Humans; Interferons; Membrane Glycoproteins; T-Lymphocytes; Ursodeoxycholic Acid; Viral Core Proteins | 2003 |
Acute seronegative hepatitis C manifesting itself as adult giant cell hepatitis--a case report and review of literature.
Topics: Hepacivirus; Hepatitis C; Humans; Male; Methylprednisolone; Middle Aged; RNA, Viral; Ursodeoxycholic Acid | 2003 |
[Therapeutic strategies for hepatitis C].
Topics: Antiviral Agents; Cysteine; Drug Combinations; Drug Therapy, Combination; Genotype; Glycine; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon Type I; Interferon-alpha; Interferons; Oleanolic Acid; Pharmacogenetics; Phlebotomy; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Ursodeoxycholic Acid | 2004 |
[Hepatitis 2004: an update].
Topics: Antiviral Agents; Biopsy; Cholagogues and Choleretics; Clinical Enzyme Tests; Diagnosis, Differential; Hepatitis; Hepatitis A; Hepatitis B; Hepatitis C; Hepatitis D; Hepatitis E; Hepatitis, Alcoholic; Humans; Laparoscopy; Liver; Liver Cirrhosis; Liver Cirrhosis, Biliary; Liver Diseases; Liver Transplantation; Physical Examination; Ultrasonography; Ursodeoxycholic Acid; Weight Loss | 2004 |
[Therapy of chronic non-active hepatitis].
Topics: Clinical Trials as Topic; Hepatitis B; Hepatitis C; Humans; Interferons; Ursodeoxycholic Acid | 1994 |
[Alternative treatment to interferon therapy in chronic viral hepatitis].
Topics: Acetylcysteine; Adjuvants, Immunologic; Antisense Elements (Genetics); Antiviral Agents; Cholagogues and Choleretics; Hepatitis B; Hepatitis C; Hepatitis, Chronic; Humans; Immunosuppressive Agents; Interferon Inducers; Poly A-U; RNA, Catalytic; Ursodeoxycholic Acid | 1995 |
[Treatment of viral hepatitis C: what are the perspectives?].
Topics: Acetylcysteine; Adult; Age Factors; Drug Therapy, Combination; Female; Hepatitis C; Humans; Interferon-alpha; Ketoprofen; Male; Middle Aged; Prognosis; Ribavirin; Sex Factors; Time Factors; Ursodeoxycholic Acid | 1994 |
[Chronic non-suppurative destructive cholangitis (CNSDC)].
Topics: Autoimmune Diseases; Graft vs Host Disease; Hepatitis C; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid | 1996 |
[Treatment of chronic hepatitis C: still many problems pending].
Topics: Adrenal Cortex Hormones; Aged; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Cholagogues and Choleretics; Chronic Disease; Clinical Enzyme Tests; Drug Therapy, Combination; Hepatitis C; HIV Infections; Humans; Indomethacin; Interferons; Ofloxacin; Phlebotomy; Recurrence; Ribavirin; Time Factors; Ursodeoxycholic Acid | 1997 |
[Use of ursodeoxycholic acid in treatment of chronic hepatitis C].
Topics: Chronic Disease; Drug Therapy, Combination; Hepatitis C; Humans; Interferon-alpha; Remission Induction; Ursodeoxycholic Acid | 1996 |
[Prevention of development of hepatocellular carcinoma from HCV-associated liver cirrhosis by multi-agents therapy including stronger-neo-minophagen C].
Topics: Anti-Inflammatory Agents; Carcinoma, Hepatocellular; Clinical Trials as Topic; Cysteine; Drug Combinations; Drug Therapy, Combination; Drugs, Chinese Herbal; Glycine; Glycyrrhetinic Acid; Hepatitis C; Humans; Liver Cirrhosis; Liver Neoplasms; Risk; Treatment Outcome; Ursodeoxycholic Acid | 2001 |
15 trial(s) available for ursodeoxycholic acid and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
| Article | Year |
|---|---|
[Peripheral blood lymphocyte apoptosis in children with viral hepatites A, B, C and effect of ursodeoxycholic acid preparations].
Topics: Acute Disease; Adolescent; Apoptosis; Child; Child, Preschool; Cholagogues and Choleretics; Chronic Disease; Flow Cytometry; Hepatitis A; Hepatitis B; Hepatitis C; Humans; Lymphocytes; Ursodeoxycholic Acid | 2008 |
Treatments for hepatitis C: refinements in the recipe?
Topics: Combined Modality Therapy; Female; Hepatitis C; Hepatitis, Chronic; Humans; Interferons; Male; Middle Aged; Ursodeoxycholic Acid | 1995 |
A multicenter randomized controlled dose study of ursodeoxycholic acid for chronic hepatitis C.
Topics: Alanine Transaminase; Bile Acids and Salts; Chronic Disease; Dose-Response Relationship, Drug; Female; gamma-Glutamyltransferase; Hepacivirus; Hepatitis C; Humans; Liver; Male; Middle Aged; Osmolar Concentration; RNA; Ursodeoxycholic Acid | 1994 |
Effects of ursodeoxycholic acid on serum liver enzymes in patients with hepatitis C virus-related chronic liver disease.
Topics: Adult; Alanine Transaminase; Female; gamma-Glutamyltransferase; Hepatitis C; Humans; Male; Ursodeoxycholic Acid | 1995 |
Interferon and ursodeoxycholic acid combined therapy in the treatment of chronic viral C hepatitis: results from a controlled randomized trial in 80 patients.
Topics: Adult; Alanine Transaminase; Base Sequence; Biopsy; Chronic Disease; Clinical Protocols; Combined Modality Therapy; Female; Follow-Up Studies; gamma-Glutamyltransferase; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Molecular Sequence Data; Recombinant Proteins; RNA, Viral; Ursodeoxycholic Acid | 1995 |
Recombinant interferon-alpha and ursodeoxycholic acid versus interferon-alpha alone in the treatment of chronic hepatitis C: a randomized clinical trial with long-term follow-up.
Topics: Adult; Chronic Disease; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C; Humans; Interferon-alpha; Male; Middle Aged; Probability; Recombinant Proteins; Recurrence; Regression Analysis; Treatment Outcome; Ursodeoxycholic Acid | 1995 |
[Effect of long-term ursodeoxycholic acid treatment on serum liver enzymes and serum bile acid metabolism in chronic hepatitis].
Topics: Aged; Bile Acids and Salts; Chronic Disease; Female; Hepatitis; Hepatitis B; Hepatitis C; Humans; Liver; Liver Function Tests; Middle Aged; Retrospective Studies; Ursodeoxycholic Acid | 1995 |
Ursodeoxycholic acid and chronic hepatitis C infection.
Topics: Alanine Transaminase; Chronic Disease; Female; gamma-Glutamyltransferase; Hepatitis C; Humans; Male; Ursodeoxycholic Acid | 1993 |
Efficacy of ursodeoxycholic acid therapy in chronic viral hepatitis C with high serum gamma-glutamyltranspeptidase levels.
Topics: Administration, Oral; Adult; Aged; Cholagogues and Choleretics; Chronic Disease; Female; gamma-Glutamyltransferase; Hepatitis C; Humans; Linear Models; Liver; Male; Middle Aged; Treatment Outcome; Ursodeoxycholic Acid | 1996 |
Efficacy of ursodeoxycholic acid in combination with interferon-alpha in treating chronic hepatitis C: results of a long-term follow-up trial.
Topics: Alanine Transaminase; Antiviral Agents; Cholagogues and Choleretics; Chronic Disease; Drug Therapy, Combination; Female; Follow-Up Studies; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Male; Middle Aged; Prospective Studies; RNA, Viral; Ursodeoxycholic Acid; Viremia | 1996 |
Efficacy of combination therapy of interferon-alpha with ursodeoxycholic acid in chronic hepatitis C: a randomized controlled clinical trial.
Topics: Administration, Oral; Alanine Transaminase; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C; Hepatitis, Chronic; Humans; Injections, Intramuscular; Interferon-alpha; Leukocyte Count; Male; Middle Aged; Platelet Count; RNA, Messenger; Ursodeoxycholic Acid | 1997 |
Long-term efficacy of interferon-alpha and ursodeoxycholic acid in treatment of chronic type C hepatitis.
Topics: Alanine Transaminase; Antiviral Agents; Cholagogues and Choleretics; Clinical Enzyme Tests; Cross-Over Studies; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepatitis C; Hepatitis, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Recombinant Proteins; Time Factors; Ursodeoxycholic Acid | 1997 |
Interferon plus ursodeoxycholic acid versus interferon in the treatment of chronic C viral hepatitis.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Cholagogues and Choleretics; Chronic Disease; Drug Therapy, Combination; Female; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Liver Function Tests; Male; Middle Aged; Recombinant Proteins; Recurrence; Ursodeoxycholic Acid | 1997 |
Tumor necrosis factor-alpha and transforming growth factor-beta reflect severity of liver damage in primary biliary cirrhosis.
Topics: Adult; Biomarkers; Biopsy; Cholagogues and Choleretics; Cholangitis, Sclerosing; Double-Blind Method; Female; Hepatitis C; Humans; Liver; Liver Cirrhosis, Biliary; Liver Diseases, Alcoholic; Male; Middle Aged; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Ursodeoxycholic Acid | 2002 |
[Ursodeoxycholic hemisuccinate in the treatment of chronic active hepatitis. A controlled clinico-therapeutic study].
Topics: Adult; Aged; Female; Hepatitis B; Hepatitis C; Hepatitis, Chronic; Humans; Liver; Male; Middle Aged; S-Adenosylmethionine; Ursodeoxycholic Acid | 1992 |
16 other study(ies) available for ursodeoxycholic acid and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
| Article | Year |
|---|---|
Risk Factors of Glecaprevir/Pibrentasvir-Induced Liver Injury and Efficacy of Ursodeoxycholic Acid.
Topics: Aged; Chemical and Drug Induced Liver Injury, Chronic; Coloring Agents; Hepatitis C; Humans; Risk Factors; Ursodeoxycholic Acid | 2023 |
A dose-up of ursodeoxycholic acid decreases transaminases in hepatitis C patients.
Topics: Adult; Aged; Aged, 80 and over; Alanine Transaminase; Animals; Aspartate Aminotransferases; Bilirubin; Blood Platelets; Dose-Response Relationship, Drug; Female; gamma-Glutamyltransferase; Hepacivirus; Hepatitis C; Humans; Male; Middle Aged; Serum Albumin; Ursodeoxycholic Acid | 2009 |
Long-term virological follow up of patients with occult hepatitis C virus infection.
Topics: Adult; Aged; Biomarkers; Female; Follow-Up Studies; Hepatitis C; Humans; Leukocytes, Mononuclear; Liver; Male; Middle Aged; RNA, Viral; Statistics, Nonparametric; Ursodeoxycholic Acid | 2011 |
Ursodiol use is possibly associated with lower incidence of hepatocellular carcinoma in hepatitis C virus-associated liver cirrhosis.
Topics: Alanine Transaminase; Analysis of Variance; Carcinoma, Hepatocellular; Cell Transformation, Neoplastic; Cholagogues and Choleretics; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Glycyrrhizic Acid; Hepacivirus; Hepatitis C; Humans; Incidence; Inflammation; Liver Cirrhosis; Liver Neoplasms; Logistic Models; Male; Middle Aged; Risk Factors; Treatment Outcome; Ursodeoxycholic Acid | 2005 |
[Features and therapy of the patients with chronic hepatitis C resistant to IFN therapy].
Topics: Antiviral Agents; Chronic Disease; Drug Resistance; Hepatitis C; Humans; Interferons; Treatment Outcome; Ursodeoxycholic Acid | 1995 |
Ursodeoxycholic acid for chronic hepatitis C patients.
Topics: Alanine Transaminase; Chronic Disease; Hepatitis C; Humans; Ursodeoxycholic Acid | 1995 |
[A case of primary biliary cirrhosis associated with chronic active hepatitis type C improved by the injection of interferon and the administration of ursodeoxycholic acid].
Topics: Female; Hepatitis C; Hepatitis, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis, Biliary; Middle Aged; Recombinant Proteins; Ursodeoxycholic Acid | 1993 |
Effect of ursodeoxycholic acid on HCV replication in subtyped chronic hepatitis C.
Topics: Chronic Disease; Hepacivirus; Hepatitis C; Humans; Ursodeoxycholic Acid; Virus Replication | 1996 |
Ursodeoxycholic acid therapy in recurrent or acquired genotype II hepatitis C virus infection after liver transplantation: a three-case report.
Topics: Adult; Female; Gastrointestinal Agents; Genotype; Hepacivirus; Hepatitis B; Hepatitis C; Humans; Liver Cirrhosis; Liver Function Tests; Liver Transplantation; Male; Middle Aged; Recurrence; RNA, Viral; Ursodeoxycholic Acid | 1996 |
Ursodeoxycholic acid corrects defective natural killer activity by inhibiting prostaglandin E2 production in primary biliary cirrhosis.
Topics: Adult; Aged; Cells, Cultured; Chenodeoxycholic Acid; Cholic Acid; Cholic Acids; Chronic Disease; Deoxycholic Acid; Dinoprostone; Female; Hepatitis C; Humans; Indomethacin; Killer Cells, Natural; Liver Cirrhosis, Biliary; Liver Diseases; Male; Middle Aged; Ursodeoxycholic Acid | 1996 |
Ursodeoxycholic acid. Actigall, Urso, Ursobilane, Ursochol, ursodesoxycholic acid, ursodiol, Ursolite, Ursolvan.
Topics: Animals; Antiviral Agents; Clinical Trials, Phase II as Topic; Hepatitis C; Humans; Ursodeoxycholic Acid | 1999 |
Changes of liver fibrosis in chronic hepatitis C patients with no response to interferon-alpha therapy: including quantitative assessment by a morphometric method.
Topics: Alanine Transaminase; Antiviral Agents; Biomarkers; Biopsy; Disease Progression; Drugs, Chinese Herbal; Female; Glycyrrhizic Acid; Hepatitis C; Hepatitis C, Chronic; Humans; Injections, Intramuscular; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Peptide Fragments; Procollagen; Retrospective Studies; RNA, Viral; Ursodeoxycholic Acid | 2000 |
Thioredoxin levels in the sera of untreated viral hepatitis patients and those treated with glycyrrhizin or ursodeoxycholic acid.
Topics: Adult; Aged; Case-Control Studies; Female; Glycyrrhizic Acid; Hepatitis B; Hepatitis C; Humans; Indocyanine Green; Lipid Peroxides; Male; Middle Aged; Oxidative Stress; Thioredoxins; Ursodeoxycholic Acid | 2000 |
[Diagnosis and therapy of hepatitis C].
Topics: Genotype; Hepacivirus; Hepatitis C; Humans; Interferon-gamma; Liver; Recombinant Proteins; RNA, Viral; Ursodeoxycholic Acid | 1992 |
Cytoprotection in the nineties: experience with ursodeoxycholic acid and silymarin in chronic liver disease.
Topics: Chronic Disease; Female; Hepatitis C; Humans; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Prospective Studies; Silymarin; Ursodeoxycholic Acid | 1992 |
Clinical evidence of hepatoprotection induced by ursodeoxycholic acid.
Topics: Aged; Bilirubin; Cholestasis, Intrahepatic; Chronic Disease; Hepatitis Antibodies; Hepatitis C; Humans; Liver Function Tests; Male; Prednisolone; Ursodeoxycholic Acid | 1992 |